Stay updated with breaking news from Daniel Vitt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Investor Conferences in September 01.09.2022 / 12:30 CET/CEST The issuer is solely responsible for
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...
NEW YORK, Aug. 16, 2022 /PRNewswire/ -- Immunic, Inc. , a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic... | August 16, 2022
Immunic, Inc. (NASDAQ:NASDAQ:IMUX) Q2 2022 Earnings Conference Call August 4, 2022 08:00 ET Company Participants Jessica Breu - Head, Investor Relations and Communications Daniel Vitt -...
/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused...